| ISIN | IE00B39YK708 | 
|---|---|
| Valor Number | 4413092 | 
| Bloomberg Global ID | WGHCEQT ID | 
| Fund Name | Wellington Management Funds (Ireland) plc - Wellington Global Health Care Equity Fund GBP T AccU | 
| Fund Provider | 
                                            
                                            
                                            Wellington Management Company LLP
                                            
                                            
                                            
                                            
    
        
            Web: https://www.wellingtonfunds.com | 
                                    
| Fund Provider | Wellington Management Company LLP | 
| Representative in Switzerland | 
                                            BNP Paribas, Paris, Zurich Branch Zürich  | 
                                    
| Distributor(s) | Wellington Global Administrator, Ltd. | 
| Asset Class | Equities | 
| EFC Category | Equity Health Care | 
| Distribution Policy | Accumulation | 
| Home Country | Ireland | 
| Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) | 
| Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) | 
| Investment Strategy *** | The investment objective of the Fund is to seek long-term total returns. The Investment Manager will actively manage the Fund, seeking to outperform the MSCI World Health Care Index (the "Index”) and achieve the objective, primarily through investment in the equity securities of health care companies worldwide. | 
| Peculiarities | 
| Current Price * | 103.85 GBP | 03.11.2025 | 
|---|---|---|
| Previous Price * | 104.49 GBP | 31.10.2025 | 
| 52 Week High * | 106.04 GBP | 02.12.2024 | 
| 52 Week Low * | 84.25 GBP | 14.05.2025 | 
| NAV * | 103.85 GBP | 03.11.2025 | 
| Issue Price * | ||
| Redemption Price * | ||
| Closing Price * | ||
| Indicative Minimum Price | ||
| Fund Assets *** | 874,832,307 | |
| Unit/Share Assets *** | 10,051,603 | |
| Trading Information SIX | ||
| YTD Performance | +5.05% | 
        31.12.2024 - 03.11.2025
        31.12.2024 03.11.2025  | 
                                    
|---|---|---|
| YTD Performance (in CHF) | -2.23% | 
        31.12.2024 - 03.11.2025
        31.12.2024 03.11.2025  | 
                                        
| 1 month | +4.03% | 
        03.10.2025 - 03.11.2025
        03.10.2025 03.11.2025  | 
                                    
| 3 months | +15.60% | 
        04.08.2025 - 03.11.2025
        04.08.2025 03.11.2025  | 
                                    
| 6 months | +14.14% | 
        05.05.2025 - 03.11.2025
        05.05.2025 03.11.2025  | 
                                    
| 1 year | +0.03% | 
        04.11.2024 - 03.11.2025
        04.11.2024 03.11.2025  | 
                                    
| 2 years | +13.11% | 
        03.11.2023 - 03.11.2025
        03.11.2023 03.11.2025  | 
                                    
| 3 years | +3.84% | 
        03.11.2022 - 03.11.2025
        03.11.2022 03.11.2025  | 
                                    
| 5 years | +19.43% | 
        03.11.2020 - 03.11.2025
        03.11.2020 03.11.2025  | 
                                    
| Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ADDI Date | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Eli Lilly and Co | 9.32% | |
|---|---|---|
| AstraZeneca PLC | 4.88% | |
| UnitedHealth Group Inc | 4.24% | |
| Merck & Co Inc | 3.73% | |
| Edwards Lifesciences Corp | 2.71% | |
| AbbVie Inc | 2.70% | |
| Boston Scientific Corp | 2.69% | |
| Vertex Pharmaceuticals Inc | 2.69% | |
| Johnson & Johnson | 2.62% | |
| argenx SE | 2.62% | |
| Last data update | 30.09.2025 | |
| TER | 0.08% | 
|---|---|
| TER date | 15.09.2023 | 
| Performance Fee *** | |
| PTR | |
| Max. Management Fee *** | |
| Ongoing Charges *** | 0.09% | 
| 
                                            SRRI ***
                                             | 
                                    |
| SRRI date *** | 31.10.2025 |